These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11049050)

  • 1. Targeting progress: the development of growth factor receptor-directed therapy.
    Hortobagyi GN; Khayat D
    Semin Oncol; 2000 Oct; 27(5 Suppl 9):1-2. PubMed ID: 11049050
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecular targeting therapy for breast neoplasms].
    Horiguchi J
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():415-21. PubMed ID: 17682186
    [No Abstract]   [Full Text] [Related]  

  • 3. [New development in the treatment of breast cancer. II. Future anti-HER2 therapy].
    Yamashita T; Iwata K
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2551-4. PubMed ID: 20104676
    [No Abstract]   [Full Text] [Related]  

  • 4. Refining therapy for human epidermal growth factor receptor 2-positive breast cancer: T stands for trastuzumab, tumor size, and treatment strategy.
    Burstein HJ; Winer EP
    J Clin Oncol; 2009 Dec; 27(34):5671-3. PubMed ID: 19884535
    [No Abstract]   [Full Text] [Related]  

  • 5. Herceptin.
    Peyrot J
    Oncol Nurs Forum; 1999 Apr; 26(3):515-6. PubMed ID: 10214591
    [No Abstract]   [Full Text] [Related]  

  • 6. What is the ideal HER2 test for Herceptin therapy?
    Jpn J Clin Oncol; 2000 Apr; 30(4):208-9, 211. PubMed ID: 10830993
    [No Abstract]   [Full Text] [Related]  

  • 7. [Trastuzumab. Monoclonal antibody for the treatment of breast cancer].
    Heinzl S
    Med Monatsschr Pharm; 2000 Nov; 23(11):350-2. PubMed ID: 11103587
    [No Abstract]   [Full Text] [Related]  

  • 8. [Herceptin].
    Morginstin T; Shani S; Shemer J
    Harefuah; 2000 Mar; 138(6):459-64. PubMed ID: 10883160
    [No Abstract]   [Full Text] [Related]  

  • 9. Trastuzumab in breast cancer.
    Banna GL; Santoro A
    N Engl J Med; 2006 Feb; 354(6):640-4; author reply 640-4. PubMed ID: 16470951
    [No Abstract]   [Full Text] [Related]  

  • 10. Making real progress against breast cancer. Some of the best cancer news this year has been the success of targeted approaches to treating breast cancer.
    Harv Womens Health Watch; 2005 Oct; 13(2):1-3. PubMed ID: 16320417
    [No Abstract]   [Full Text] [Related]  

  • 11. Lapatinib: new directions in HER2 directed therapy for early stage breast cancer.
    Jo Chien A; Rugo HS
    Cancer Treat Res; 2009; 151():197-215. PubMed ID: 19593514
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent trends of HER-2 examination and a new strategy of trastuzumab therapy for primary and metastatic breast cancer.
    Kurosumi M
    Breast Cancer; 2009; 16(4):283. PubMed ID: 19756922
    [No Abstract]   [Full Text] [Related]  

  • 13. Can strategies targeting cleaved MUC1 overcome resistance to trastuzumab?
    Araki K; Pegram M
    Breast Cancer Res Treat; 2011 Jun; 127(2):589-90. PubMed ID: 19834800
    [No Abstract]   [Full Text] [Related]  

  • 14. ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines.
    Ginestier C; Adélaïde J; Gonçalvès A; Repellini L; Sircoulomb F; Letessier A; Finetti P; Geneix J; Charafe-Jauffret E; Bertucci F; Jacquemier J; Viens P; Birnbaum D
    Oncogene; 2007 Nov; 26(50):7163-9. PubMed ID: 17525746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trastuzumab.
    Perez EA; Palmieri FM; Brock SM
    Cancer Treat Res; 2009; 151():181-96. PubMed ID: 19593513
    [No Abstract]   [Full Text] [Related]  

  • 16. Trastuzumab in the treatment of breast cancer.
    Hortobagyi GN
    N Engl J Med; 2005 Oct; 353(16):1734-6. PubMed ID: 16236745
    [No Abstract]   [Full Text] [Related]  

  • 17. Introduction. Herceptin: HER2 status--changing clinical practice.
    Piccart M; Kaufmann M
    Eur J Cancer; 2001 Jan; 37 Suppl 1():S1-2. PubMed ID: 11167084
    [No Abstract]   [Full Text] [Related]  

  • 18. Trastuzumab in breast cancer.
    Gounaris IG
    N Engl J Med; 2006 Feb; 354(6):640-4; author reply 640-4. PubMed ID: 16470950
    [No Abstract]   [Full Text] [Related]  

  • 19. Trastuzumab in breast cancer.
    Gilbert SG
    N Engl J Med; 2006 Feb; 354(6):640-4; author reply 640-4. PubMed ID: 16467555
    [No Abstract]   [Full Text] [Related]  

  • 20. Individualization of neoadjuvant therapy for breast cancer according to molecular tumor characteristics.
    Hennessy BT; Gonzalez-Angulo AM; Hortobagyi GN
    Nat Clin Pract Oncol; 2005 Dec; 2(12):598-9. PubMed ID: 16341096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.